NCT06730555Active, not recruiting
Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 9 Dec 2024
- Start date
- 27 Jun 2025
- Primary completion date
- 1 Aug 2028
- Lead sponsor
- University of Miami
- Diseases
- HIV
- NCT number
- NCT06730555
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 27 Jun 2025 to the primary completion date, 1 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- SSPs must not:
- currently receive or have received Frontline Communities in the United States (FOCUS) funding;
- have already implemented opt-out HIV/HCV testing.
- currently participating in SAIA-SSP-HIV (NCT06025435)
Who the study is looking for
- SSPs must:
- be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
- serve at least 300 unique participants per year;
- not currently offer opt-out HIV/HCV testing;
- be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
- have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.